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IndonesiaAbstract Background: Single nucleotide polymorphism (SNP) within tumor necrosis factor alpha
(TNF-a) gene promoter (308G/A TNFA) is associated with higher gene expression. The role of
this SNP as a risk factor for spontaneous preterm birth has been assessed in some regions and
the ﬁndings were signiﬁcantly different between race and ethnic groups.
Aim: To provide the scientiﬁc evidence whether allele A within SNP 308G/A TNFA promoter
is a risk factor for spontaneous preterm birth among Acehnese ethnic or not.
Subjects and methods: In this case–control study, the genotypes of SNP 308G/A TNFA among
40 patients with spontaneous preterm birth and 40 patients with term birth were determined by real-
time polymerase chain reaction (RT-PCR). The concentrations of TNF-a from blood were mea-
sured by enzyme-linked immunosorbent assay (ELISA). The differences in genotype distributions,
dominant and recessive models, and allele frequencies between case and control groups were ana-
lyzed with Chi-squared test. Deviation of genotype frequencies from the Hardy–Weinberg equilib-
rium (HWE) was assessed by Fisher’s exact test.
34 M. Andalas et al.Results: This study found that the concentration of TNF-a between preterm and control groups
was not statistically different, 5.5 ± 2.9 mg/dL vs. 10.1 ± 17.9 mg/dL, p= 0.112. The level of
TNF-a had no strong association with either genotype distribution or allele frequency of SNP
308G/A TNFA. Furthermore, there was no association between mutant genotypes and sponta-
neous preterm birth (OR: 0.32; 95%CI: 0.08–1.33, p= 0.096) and between mutant allele and spon-
taneous preterm birth (OR: 0.35; 95%CI: 0.09–1.37, p= 0.105).
Conclusion: SNP 308G/A TNFA is not associated with spontaneous preterm birth in Acehnese
ethnic group.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The preterm birth is deﬁned as birth that occurs before
37 weeks of pregnancy [1]. The prevalence of preterm birth
ranges from 5% in high income countries to 25% in low
income countries [1]. Preterm birth is associated with massive
economic burden and causes emotional distress to the parents
[2]. Approximately 30% of preterm birth are caused by mater-
nal or fetal complications such as preeclampsia or intrauterine
growth restriction whereas 70% of them caused by sponta-
neous preterm labor [3].
Preterm is associated with multiple mechanisms of disease
that could switch of the myometrium from a quiescent to a
contractile state, mostly is accompanied by a shift in signaling
from anti-inﬂammatory to pro-inﬂammatory pathways [4].
Increased expression of pro-inﬂammatory cytokines including
tumor necrosis factor alpha (TNF-a), one of the most potent
pro-inﬂammatory cytokines, and chemokines increases activity
of proteases leading to extracellular matrix components
dissolution [4].
TNF-a, a key pro-inﬂammatory cytokine, is an important
regulatory molecule during pregnancy and its production is
regulated both at the transcriptional and posttranscriptional
levels [5]. Several single nucleotide polymorphisms (SNPs) have
been identiﬁed within TNF-a gene (TNFA) [5] and one of the
most intensively studied is SNP 308G/A that is located in
TNFA promoter. In this SNP, homozygote AA and heterozy-
gote GA are associated with increased TNFA gene expression
compared to homozygous GG [6]. Several studies have been
conducted to assess the association between this SNP and spon-
taneous preterm birth [7–11]. However, data revealed that the
associations of SNP308G/ATNFA and spontaneous preterm
birth (and TNF-a level) differ signiﬁcantly between race and
ethnic groups [9,12,13]. Therefore, studies of the role of this
SNP on spontaneous preterm birth in other race and ethnic
groups are need. The objective of this present study was to
determine the association between SNP 308G/A TNFA and
spontaneous preterm birth among the Acehnese ethnic group.
2. Subjects and methods
2.1. Study setting
The approach of this case-control study was adopted from a
previous study that was published by our group [14]. The cases
were women with spontaneous preterm birth who came for
treatment at Dr. Zainoel Abidin, Banda Aceh, Indonesia.
Preterm birth cases were diagnosed using the criteria fromThe American Congress of Obstetricians and Gynecologists
(ACOG). The controls were women with term birth based
on ACOG criteria who were age-, and race-matched and not
related to the cases. The preterm birth is deﬁned as the birth
occurring between 20 and 37 weeks of pregnancy, whereas
term birth is deﬁned as the birth after 37 weeks of gestation.
Patients aged over 50 years and patients who had preeclamp-
sia, signs and symptoms of infection, autoimmune disease,
obesity, pregnancy with intrauterine growth restriction, twin
baby, placental previa, fetal anomalies, gestational diabetes,
poly- and oligohydramnios were excluded.
At the admission time, clinical signs and symptoms and
gynecology conditions were assessed and venous blood sam-
ples were collected under strictly standardized conditions and
stored at 80 C before being used. This study has been
approved by the Ethics Committee of School of Medicine,
Syiah Kuala University, Banda Aceh, Indonesia, No.
111/KE/FK/2012. The subject recruitment and sample collec-
tion were done only after obtaining written informed consent
of the participants. The work was carried out in accordance
with The Code of the World Medical Association
(Declaration of Helsinki) for experiments involving humans.
This study was conducted from 1 June 2012 to 30 July 2014.
2.2. Immunologic assay of TNF-a
The concentrations of TNF-a from blood sera were measured
with a solid phase sandwich enzyme-linked immunosorbent
assay (ELISA) using microtitre plates from Human
TNF-alpha Quantikine ELISA Kit (R&D Systems, USA)
per manufacture protocol. The ELISA has detection range
7.8–1.000 pg/mL and sensitivity 1.6 pg/mL.
2.3. Deoxyribonucleic acid (DNA) extraction
DNA isolation and real-time polymerase chain reaction (RT-
PCR) were conducted in Prodia Laboratory, Jakarta. For
DNA extraction purpose, 5 mL peripheral venous blood was col-
lected from 80 subjects (40 cases and 40 controls). DNA was
extracted from whole blood using the salting-out method as
described previously [15]. DNA extraction and puriﬁcation were
completely performed according to high pure PCR template
preparation kit instructions (Roche Applied Biosystem, USA).
2.4. SNP 308G/A TNFA genotyping
Genotyping of SNP 308G/A TNFA was performed by using
a RT-PCR with speciﬁc ﬂuorescence-labeled hybridization
Table 2 The association of SNP 308G/A TNFA and TNF-a
level (n= 80).
Genotype
and allele
Frequency,
n (%)
TNF-a level
(mean ± SD, mg/dL)
p-Value*
Genotype 0.612
GG 69 (86.2) 8.1 ± 13.9
GA 11 (13.8) 5.9 ± 2.7
AA 0 –
Dominant model 0.612
GA+ AA 11 (13.8) 5.9 ± 2.7
GG 69 (86.2) 8.1 ± 13.9
Allele 0.105
G 149 (93.1) 5.9 ± 2.7
A 11 (6.9) 7.9 ± 13.4
SD: standard deviation.
* p-Value measured by Anova test.
Table 3 The association of SNP 308G/A TNFA and
Figure 1 The comparison of TNF-a level between spontaneous
preterm birth and term birth group.
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gene target, the primers (sense, 50-AAGGAAACAGACCAC
AGACCTG; antisense, 50-GGTCTTCTGGGCCACTGAC)
were used at 0.5 lmol/liter. In addition, the detection probe
speciﬁc for the G allele (50-AACCCCGTCCCCATGCC) and
the anchor probe (50-CAAAACCTATTGCCTCCATTTCTT
TTGGGGAC) were used at 0.2 lmol/liter. Ampliﬁcation
was performed with 60 cycles (denaturation at 95 C for
1 min, annealing at 57 C for 15 s, extension at 72 C for
10 s) in a total 10-lL PCR mixture containing 1 lL of reaction
buffer. PCR reagents from LightCyclerFastStart DNA
MasterPLUSHybProbe (Roche Applied Biosystem, USA)
were used. The thermocycler was a Light-Cycler 2.0 (Roche
Applied Biosystem, USA). Finally, the genotypes of each sam-
ple were classiﬁed as AA, GA, and GG according to the
derivative melting curves [16].
2.5. Statistical analysis
The data were analyzed using methods that have been pub-
lished previously [17,18]. Collectively, demographic data and
the level of TNF-a between case and control groups were ana-
lyzed with Anova or Student’s t-test as appropriate with data.
To assess the association between SNP 308G/A TNFA and
the incidence of spontaneous preterm birth, the differences in
genotype distributions, dominant and recessive models, and
allele frequencies between case and control groups were ana-
lyzed with Chi-squared test. Deviation of the genotype fre-
quencies from the Hardy–Weinberg equilibrium (HWE) was
assessed by Fisher’s exact test. Two sided of testing was used
for all comparisons and p< 0.05 was considered as signiﬁcant.
The data were analyzed using Statistical Package for the Social
Sciences (SPSS for Windows, Ver. 15, Chicago, IL).
3. Results
3.1. Sample characteristics and TNF-a concentration
A total of 80 participants, 40 cases (mean age was
30.6 ± 4.9 years old) and 40 controls (mean age was
29.9 ± 4.2 years old) were enrolled in this study. This study
found that there was no signiﬁcant difference for age between
case and control groups (Table 1). In addition, there was no
signiﬁcant difference between the level of TNF-a inTable 1 Sample characteristics of cases (n= 40) and controls
(n= 40).
Characteristic Group p-Value
Preterm, n (%) Term, n (%)
Age (year ± SD)* 30.6 ± 4.9 29.9 ± 4.2 0.448
Age group** 0.941
20–25 year 6 (15.0) 7 (17.5)
26–30 year 14 (35.0) 16 (40.0)
31–35 year 15 (37.5) 14 (35.0)
36–40 year 3 (7.5) 2 (5.0)
41–45 year 2 (5) 1 (2.5)
SD: standard deviation.
* p-Value measured by Student t-test analysis.
** p-Value measured by Anova test.spontaneous preterm birth and the control group,
5.5 ± 2.9 mg/dL and 7.5 ± 7.1 mg/dL, respectively
p= 0.112 (Fig. 1).spontaneous preterm birth.
Genotype
and allele
Group OR (CI 95%) p-Value*
Preterm,
n (%)
Term,
n (%)
Genotype 0.32 (0.08–1.33) 0.096
GG 37 (92.5) 32 (80)
GA 3 (7.5) 8 (20)
AA 0 0
Dominant model 0.32 (0.08–1.33) 0.096
GA+ AA 3 (7.5) 8 (20)
GG 37 (92.5) 32 (80)
Allele 0.35 (0.09–1.37) 0.105
A 3 (3.7) 8 (10)
G 77 (96.3) 72 (90)
OR: odd ratio.
* p-value measured by Chi-squared test.
Figure 2 (A) The melting curve of RT-PCR of SNP 308G/A TNFA. The melting temperature for GG homozygote is 68 C, GA
heterozygote is 68 C and AA homozygote is 59 C. (B) The structure of TNFA and the location of SNP 308G/A TNFA. TNFA consists
of four exons: exon 1 (338 bp) encodes the 50 untranslated region (50UTR) and a majority of the signal sequence, exon 2 (46 bp) encodes
the rest of the signal sequence, exon 3 (48 bp) encodes the mature TNF-a protein and exon 4 (1210 bp) encodes the mature TNF-a protein
and the 30UTR. SNP 308G/A TNFA is located on TNFA promoter [19]. (C) TNFA, ﬂanked by lymphotoxin alpha (LTA) and
lymphotoxin beta (LTB), is encoded in the region of the human major histocompatibility complex (HLA) class III on chromosome 6
(6p21.3). The red arrow indicates gene orientation.
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Table 4 The list of studies that conducted to assess the association between SNP 308G/A TNFA and spontaneous preterm birth.
Year Analysis Ethnic/country Sample
(case/control)
Association Reference
1997 Maternal Not mentioned/USA 203/41 No association [32]
1997 Fetal Not mentioned/USA 44/41 No association [32]
1999 Maternal African American/USA a 55/110 No association [23]
1999 Maternal African American/USA b 26/110 OR: 3.1 (1.33–7.83), p= 0.008 [GA+ AA vs. GG] [23]
OR: 2.1 (1.04–4.27), p= 0.03 [G vs. A]
2001 Fetal African/Kenya 34/961 RR: 7.3 (2.85–18.90), p= 0.002 [GG vs. AA] [25]
RR: 6.7 (2.00–23.00), p= 0.008 [AG vs. AA]
2003 Maternal Asian/China 54/79 [26]
OR: 12.1 (1.14–128.75), p= 0.03 [GG vs. AA]
2004 Maternal African-American & Caucasian/USA c 125/250 OR: 2.7 (1.7–4.5) [G vs. A] [13]
2004 Maternal Caucasian/Australia 202/185 No association [33]
2004 Maternal Mixed population/UK 48/82 No association [24]
OR: 3.9 (1.38–11.05), p= 0.004 [G vs. A]
2006 Maternal Mexican/Mexico 86/174 No association [34]
2006 Maternal African-American/USA 49/224 No association [9]
2006 Fetal African-American/USA 45/222 No association [9]
2006 Maternal Euro-American/USA 78/184 No association [9]
2006 Fetal Euro-American/USA 86/191 No association [9]
2006 Maternal African-American & Caucasian/USA 79/80 No association [35]
2006 Fetal African-American & Caucasian/USA 78/77 No association [35]
2007 Fetal Caucasian/Italy d 176/164 No association [7]
2007 Fetal Caucasian/Italy e 112/164 No association [7]
2007 Fetal Caucasian/Italy f 64 /164 No association [7]
2007 Maternal Caucasian/Austria g 30/1384 No association [11]
2007 Maternal Caucasian/Austria h 80/1384 No association [11]
2009 Maternal Mulatto/Brazil 113/97 No association [10]
2009 Maternal White & Mulatto/Brazil 79/104 No association [10]
2010 Maternal Asian/China 250/247 No association [36]
2010 Fetal Asian/China 250/247 No association [36]
2010 Maternal African American/USAc 81/366 No association [8]
2010 Maternal Non-Hispanic White/USAc 149/411 No association [8]
2010 Maternal Caucasian/Poland 32/63 No association [27]
2011 Maternal Mixed/USA j 33/830 OR: 7.5 (1.84–30.72), p= 0.005 [AG+ GG vs. AA] [37]
2012 Maternal Caucasian/Austria k 76/197 No association [30]
2012 Fetal Caucasian/Austria k 74/198 No association [30]
2012 Maternal Caucasian/Austria l 29/197 No association [30]
2012 Fetal Caucasian/Austria l 36/198 No association [30]
2013 Maternal Arab/Iran 64/71 No association [31]
2013 Fetal Caucasian/Australia m 46/582 No association [29]
2013 Fetal Caucasian/Australia n 120/582 No association [29]
2013 Fetal Caucasian/Australia o 166/582 No association [29]
2014 Maternal African/South Africa 34/58 No association [38]
2014 Maternal Caucasian/Poland 150/150 No association [39]
2015 Maternal Asian/Indonesia 40/40 No association This study
OR: odd ratio.
RR: relative risk.
a Idiopathic preterm and preterm with rupture of membrane.
b Preterm with rupture of membrane only.
c Preterm with and without bacterial vaginosis.
d Preterm with and without respiratory distress syndrome.
e Preterm without respiratory distress syndrome.
f Preterm with respiratory distress syndrome.
g Preterm <34 weeks.
h Preterm >34 weeks.
k Preterm without periventricular leucomalacia.
l Preterm with periventricular leucomalacia.
m Preterm without cerebral palsy.
n Preterm with cerebral palsy.
o Preterm with and without cerebral palsy.
j Preterm <28 weeks.
 Preterm among non-smoking.
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38 M. Andalas et al.3.2. Hardy–Weinberg equilibrium (HWE) analysis
Global minor allele frequency of SNP 308G/A TNFA is
0.0903 (based on NCBI data). Based on HWE calculation,
the genotype distribution among cases and overall sample
was consistent within HWE, with p= 0.80 and p= 0.51,
respectively. It indicates that the genotype distribution of sam-
ple from this study had no HWE deviation.
3.3. Association of SNP 308G/A TNFA and TNF-a
concentration
Within total study samples (cases and controls), the level of
TNF-a between individuals with G and A allele was not signif-
icantly different (5.9 ± 2.7 mg/dL vs. 7.9 ± 13.4 mg/dL,
p = 0.105) (Table 2). In addition, there is no association
between SNP 308G/A TNFA and TNF-a level in genotype
distribution and dominant model.
3.4. Association of SNP 308G/A TNFA and preterm birth
This study found that there was no signiﬁcant difference in the
genotype distributions and allele frequencies of SNP 308G/A
TNFA between case and control groups (Table 3). There was
no association between mutant genotype (GA and AA) and
spontaneous preterm birth (OR: 0.32; 95%CI: 0.08–1.33,
p= 0.096) and between mutant allele (A allele) and preterm
birth (OR: 0.35; 95%CI: 0.09–1.37, p= 0.105).4. Discussion
TNFA is located on the region of the human major histocom-
patibility complex (HLA) class III and consisting four exons
(Fig. 2) [19]. SNP 308G/A TNFA is located on TNFA pro-
moter and the genotypes of this SNP were determined by
RT-PCR using speciﬁc ﬂuorescence-label probe and melting
curve (Fig. 2). AA and GA genotype of SNP 308 TNFA have
higher gene expression rate compared to GG [6]. Therefore, in
theory, individual with one of those genotypes will produce
higher level of TNF-a cytokine.
It is clear that cytokines, including TNF-a, are important
during pregnancy and preterm labor [20]. An animal study
demonstrated that the increased TNF-a was an important fac-
tor responsible for preterm birth [21]. In humans, the concen-
tration of TNF-a in amniotic ﬂuid concentration was
associated with preterm birth among African-American race
but not Caucasian [12]. In this present study, we found that
there was no association between TNF-a concentration from
serum and spontaneous preterm birth. Interestingly, a large
study including 101,042 Danish women also revealed that
there was no association between an elevated of TNF-a from
serum during mid-pregnancy and spontaneous preterm birth
[22].
Several studies have been conducted to assess the role of
SNP 308G/A TNFA as a risk factor for spontaneous preterm
birth (Table 4). In short, it indicates that single SNP 308G/A
TNFA has no strong association with spontaneous preterm
birth. Previously, stratiﬁed analysis has been applied to ﬁnd
robust association. For example, a study found that theassociation exists between SNP 308G/A TNFA and preterm
birth with rupture of membrane, but the association did not
exist if the analysis included both preterm birth with rupture
of membrane and idiopathic preterm [23]. In the same scenar-
io, another study found an association between this SNP with
spontaneous preterm birth among non-smoking women, but
there was no association among both smoking and non-
smoking women [24]. The association of this SNP with sponta-
neous preterm birth was also different between women with
and without bacterial vaginosis [13]. It might indicate that
the role of SNP 308G/A TNFA is easily modiﬁed by certain
environmental factors.
However, it should be noted that from 1997 to 2015, only 6
out of 23 studies revealed positive association between SNP
308G/A TNFA and preterm birth [13,23–27] (Table 4).
Some of these studies found that the association exist within
speciﬁc structures only such as among non-smoking women
[24], among preterm birth with rupture of membrane [23]
and when using <28 weeks as a preterm cut point instead of
37 weeks [27]. In addition, meta-analysis study in 2006 found
that there was no strong association between SNP 308G/A
TNFA and preterm birth (OR: 1.41; 95%CI: 0.90–2.19) [28]
and these data were supported by another meta-analysis that
was published in 2013 (OR: 0.82; 95%CI: 0.65–1.03) [29].
Taking together, these data indicate that there is no strong
association between SNP 308G/A TNFA and spontaneous
preterm birth.
There are some limitations of our present study. The num-
ber of cases and the controls was relatively small. In addition,
this study did not obtain prospective data examining the effect
of SNP 308G/A TNFA on spontaneous preterm birth.
However, cross-sectional study is an acceptable study design
to determine the risk factor or protective effect of particular
SNP with any disease.
There are some recommendations that should be followed
when assessing the association between SNP and particular
disease. First, the investigator should include the race or ethnic
group of the study sample. Previous studies found that the
association of a particular SNP was associated with race or
ethnicity [9,40,41]. Second, to assess the association, the odd
ratio (OR) and 95% of conﬁdence interval (95%CI) with
p-value should be provided as some previous studies expressed
the association in p-value only [7,9,30,31]. In addition, at least,
the association of the genotype distributions, dominant model
and allele frequency to particular interested disease should be
revealed. Finally, the deviation of sample genotype frequencies
from the Hardy–Weinberg equilibrium (HWE) should be
calculated.
5. Conclusion
This study demonstrated that the levels of TNF-a are not sig-
niﬁcantly different between women with spontaneous preterm
birth and term birth. In addition, there is no association
between the levels of TNF-a among women (spontaneous pre-
term birth and term birth) and G/A transition at position 308
of TNFA promoter. Finally, there is no signiﬁcant association
between genotype distributions and allele frequency of SNP
308G/A TNFA and spontaneous preterm birth in the
Acehnese ethnic group.
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